Tonghua Dongbao Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600867.SS

Tonghua Dongbao Pharmaceutical Co., Ltd. Market Capitalization on January 27, 2025: USD 2.08 B

Tonghua Dongbao Pharmaceutical Co., Ltd. Market Capitalization is USD 2.08 B on January 27, 2025, a -19.38% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Tonghua Dongbao Pharmaceutical Co., Ltd. 52-week high Market Capitalization is USD 3.04 B on April 01, 2024, which is 46.21% above the current Market Capitalization.
Tonghua Dongbao Pharmaceutical Co., Ltd. 52-week low Market Capitalization is USD 1.98 B on January 10, 2025, which is -4.50% below the current Market Capitalization.
Tonghua Dongbao Pharmaceutical Co., Ltd. average Market Capitalization for the last 52 weeks is USD 2.43 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shanghai Stock Exchange: 600867.SS

Tonghua Dongbao Pharmaceutical Co., Ltd.

CEO	Mr. Sheng Leng Chun
IPO Date	Aug. 24, 1994
Location	China
Headquarters	Dongbao New Village
Employees	3,196
Sector	Healthcare
Industries Pharmaceuticals 3D Printing Biotechnology Composite Materials Drugstores & Retail Pharmacies Eyewear Non-Alcoholic Beverages Plastics

Description

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

Key trends

Past 5 years